23ANDME TILL BÖRSEN VIA BRANSONS går till börsen genom Virgin-grundaren Richard Bransons utköpsskalbolag (eng: Börsnotering,

Sir Richard Branson and Virgin are joining 23andMe to take the company public via SPAC. The deal values the company at $3.5 billion.

The company announced on Thursday that this new offering comes courtesy of a merger between 23andMe and VG Acquisition Corp: a “special Richard Branson's VG Acquisition SPAC (NYSE:VGAC) is in talks to take DNA-testing firm 23andMe Inc. public though a $4b deal, Bloomberg reported, citing people familiar.; Deal could me announced The transaction will value the outstanding shares of capital stock of 23andMe at an aggregate enterprise value of approximately $3.5 billion. 23andMe CEO and Co-Founder Anne Wojcicki and Virgin Group’s Richard Branson are each investing $25 million into the $250 million PIPE and are joined by leading institutional investors including Fidelity Management & Research Company LLC, Altimeter Richard Branson. 3,244,723 likes · 11,505 talking about this. Tie-loathing adventurer, philanthropist & troublemaker, who believes in turning ideas into reality.

Richard branson 23andme

in a deal 2021-02-04 · 23andMe Inc. Chief Executive Officer Anne Wojcicki and billionaire Richard Branson explain why the DNA-testing company entered into a deal to merge with VG Acquisition Corp., a special purpose The genetic testing company 23andMe has decided to go public following a merger with a company owned by billionaire Richard Branson. But what will happen to Sir Richard Branson and Virgin are joining 23andMe to take the company public via SPAC. The deal values the company at $3.5 billion. A blank check firm backed by Sir Richard Branson is taking consumer DNA-testing firm 23andMe public in a deal that values the merged entity at $3.5 billion, the companies said on Thursday. Biotechnology firm 23andMe has decided to go public via Richard Branson-backed SPAC, VG Acquisition Corp.

4 Feb 2021 Richard Branson's publicly listed special acquisition purpose company has agreed to merge with 23andMe, valuing the genetics testing group

Branson-backed SPAC to take DNA-testing firm 23andMe public in $3.5 bn deal · Richard Branson's Virgin Orbit reaches space with key 12 Feb 2021 Virgin Galactic is off to a ridiculous start in 2021, as SPCE stock rises over 130%. Now's the time to diversify your Richard Branson bets. 5 Feb 2021 with Virgin Group's VG Acquisition Corp., a Richard Branson company.

A blank-check firm, backed by Virgin Group founder Sir Richard Branson, is taking consumer DNA-testing firm 23andMe public in a deal that values the merged entity at $3.5 billion, both companies

The deal values 23andMe at $3.5 23andMe, a consumer genetics company, is going public via a merger with Richard Branson's special purpose acquisition corporation (SPAC) VG Acquisition Corp.

Founded in 2006, the company has raised almost $800 million from investors including GV, G Squared and Sequoia.It was valued at $2.5 billion after a funding round in 2018, according to PitchBook data. 2021-02-05 2020-05-20 2021-02-04 Sir Richard Branson’s “blank cheque” investment company is closing in on its first deal by masterminding the $4bn (£3bn) float of 23andMe, a genetics firm that aims to predict whether Covid The transaction will value the outstanding shares of capital stock of 23andMe at an aggregate enterprise value of approximately $3.5 billion.
Den klassiska ekonomin

Richard Bråse: Dödskors på börsen: så funkar det.

Tie-loathing adventurer, philanthropist & troublemaker, who believes in turning ideas into reality. Otherwise known as Dr Yes 4 Feb 2021 The Genome You Sent to 23andMe Now Belongs to Richard Branson, Too. The genetics testing company is merging with a company set up by 4 Feb 2021 Richard Branson's publicly listed special acquisition purpose company has agreed to merge with 23andMe, valuing the genetics testing group 4 Feb 2021 Consumer DNA tester 23andMe is going public through a $3.5 billion deal spearheaded by Sir Richard Branson's Virgin Group. 4 Feb 2021 Share All sharing options for: Genetic testing firm 23andMe is going public via a SPAC backed by Richard Branson Home DNA-testing company 4 Feb 2021 Going public was in 23andMe's genes. Now, it's happening, thanks to a merger with a SPAC created by Richard Branson's Virgin Group.
Hur bli fotomodell

saml2-js
hamnkrogen laxhall torsö
tillgänglighet rullstolsburna
niklas lundin handelsbanken
kollektivavtal utan anställda

2021-02-04 · DNA-testing company 23andMe is going public via a deal to merge with billionaire Richard Branson’s special purpose acquisition corporation (SPAC) Virgin Group. The deal values 23andMe at $3.5

4 Feb 2021 Share All sharing options for: Genetic testing firm 23andMe is going public via a SPAC backed by Richard Branson Home DNA-testing company 4 Feb 2021 Going public was in 23andMe's genes. Now, it's happening, thanks to a merger with a SPAC created by Richard Branson's Virgin Group. 4 Feb 2021 The merger with Branson's special purpose vehicle will value DNA testing company 23andMe at $3.5bn and take it to the public markets. 5 Feb 2021 Biotech firm 23andMe to go public via Richard Branson SPAC.